Latest News

HPV vaccine effectiveness dependent on age at receipt


 

FROM JAMA NETWORK OPEN

Vaccination rates increasing

Asked to comment on the findings, Rebecca Perkins, MD, professor of obstetrics and gynecology at Boston University, Boston Medical Center, pointed out that the investigators evaluated data from 2011 to 2018. “We know that HPV vaccination rates have increased over that period and continue to increase,” she emphasized in an email to this news organization.

Physicians also know that more persons are being vaccinated between the ages of 9 and 12 than was the case at the beginning of this study. “This is good news,” she said, “as it means that more adolescents now in 2022 are benefiting fully from vaccination than they were in 2011,” she added.

At the same time, Dr. Perkins acknowledged that many persons are still missing out on the chance to receive the vaccine on time – which means they are missing out on the chance to prevent cancer.

“Making sure that all adolescents receive vaccination between the ages of 9 to 12 has the potential to prevent up to 40,000 cancers every year in the U.S., [including] the most common HPV-related cancers, such as cervical cancer in women and tongue and tonsillar cancer in men,” Dr. Perkins noted.

“Thus, it’s critical that doctors and parents get the message that you can’t vaccinate too early, only too late,” she emphasized.

Dr. Edgman and Dr. Perkins report no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Vaccination tied to lower mortality in ventilated patients with COVID-19
MDedge Infectious Disease
You and the skeptical patient: Who’s the doctor here?
MDedge Infectious Disease
Vaccine adherence hinges on improving science communication
MDedge Infectious Disease
Ten-day methotrexate pause after COVID vaccine booster enhances immunity against Omicron variant
MDedge Infectious Disease
25 years of chickenpox vaccine: 91 million cases prevented
MDedge Infectious Disease
Updated Moderna booster shows greater activity against COVID in adults
MDedge Infectious Disease
Original COVID-19 vaccines fall short against Omicron subvariants for the immunocompromised
MDedge Infectious Disease
Shortage reported of antibiotic commonly used for children
MDedge Infectious Disease
RSV vaccine given during pregnancy protects newborns: Pfizer
MDedge Infectious Disease
COVID bivalent booster better vs. recent Omicron subvariants: Pfizer
MDedge Infectious Disease